Protective Effect of Valproate on Brain Cells:A Magnetic Resonance Imaging and Spectroscopy Study in Patients With Bipolar Disorder Diagnosis
Phase of Trial: Phase IV
Latest Information Update: 07 Jul 2009
At a glance
- Drugs Valproic acid (Primary)
- Indications Bipolar disorders
- Focus Biomarker; Therapeutic Use
- Sponsors Sanofi
- 31 Aug 2018 Biomarkers information updated
- 02 Jun 2009 Actual end date changed from Aug 2007 to Oct 2006 as reported by ClinicalTrials.gov.
- 26 May 2009 Primay outcome amended as reported by ClinicalTrials.gov.